Evidence map›Paper›PMID 41768629›Full record

ArticleACS omega2026

MolQuery: Prediction of Lipid Synthesizability Using Active Learning.

Jonathan Broadbent, Jiří Vymětal, Saeed Moayedpour, Michael Bailey, Saleh Riahi, Akshay Balsubramani, Peter Mikochik, Luc Even, Naresh Gunaganti, Ramesh Dasari and 5 more

Abstract read
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Jonathan BroadbentDigital R&D, Sanofi, Toronto, ON M5V1V6, Canada.ORCID https://orcid.org/0009-0000-7255-553X
Jiří VymětalDataSentics, 602 00 Brno, Czech Republic.
Saeed MoayedpourDigital R&D, Sanofi, Cambridge, Massachusetts 02141, United States.
Michael BaileyDigital R&D, Sanofi, Cambridge, Massachusetts 02141, United States.
Saleh RiahiDigital R&D, Sanofi, Cambridge, Massachusetts 02141, United States.
Akshay BalsubramanimRNA Center of Excellence, Sanofi, Waltham, Massachusetts 02451, United States.
Peter MikochikmRNA Center of Excellence, Sanofi, Waltham, Massachusetts 02451, United States.
Luc EvenmRNA Center of Excellence, Sanofi, Waltham, Massachusetts 02451, United States.ORCID https://orcid.org/0009-0009-5755-0859
Naresh GunagantimRNA Center of Excellence, Sanofi, Waltham, Massachusetts 02451, United States.
Ramesh DasarimRNA Center of Excellence, Sanofi, Waltham, Massachusetts 02451, United States.
Saswata KarmakarmRNA Center of Excellence, Sanofi, Waltham, Massachusetts 02451, United States.
Hongfeng DengmRNA Center of Excellence, Sanofi, Waltham, Massachusetts 02451, United States.
Vikram AgarwalmRNA Center of Excellence, Sanofi, Waltham, Massachusetts 02451, United States.
Ziv Bar-JosephDigital R&D, Sanofi, Cambridge, Massachusetts 02141, United States.
Sven JagerDigital R&D, Sanofi, Cambridge, Massachusetts 02141, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the field of molecular design, Generative Artificial Intelligence (GenAI) has the potential to create extensive synthetic data sets encompassing a wide range of chemical properties. However, the practical application of these data sets is often constrained by the synthesizability of the molecules within. To address this, it is essential to develop a robust platform for assessing synthesizability, which is crucial for constructing effective GenAI-based models for molecular systems. Here, we introduces MolQuery, a comprehensive pipeline that integrates active learning (AL) to improve the accuracy of chemical synthesizability predictions for lipid molecules designed for mRNA delivery via lipid nanoparticles (LNPs). By leveraging AL, MolQuery efficiently trains machine learning models using small data sets which greatly improves upon current solutions for this tasks. Our results demonstrate that MolQuery produces highly accurate predictions of lipid synthesizability, making it a valuable tool for filtering synthetic LNP data sets.

Identifiers

PMID41768629
PMCPMC12946983

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.